ScinoPharm Taiwan Ltd (台灣神隆), which makes active pharmaceutical ingredients, is upbeat on contract manufacturing sales growth as a new antibiotic product developed by a client has gained approval from the US Food and Drug Administration.
Baxdela, an antibiotic to treat acute bacterial skin and skin structure infections developed by US-based Melinta Therapeutics, is expected to contribute millions of US dollars annually, ScinoPharm said.
About 3 million people are hospitalized each year in the US, many of whom develop skin infections, leading to treatment challenges on top of underlying medical conditions, the company said, adding that optimal antibiotic selection in such cases is more difficult.
Amid growing concerns about drug resistance, US authorities have granted Baxdela qualified infectious disease product designation, extending to its developer five years of market exclusivity as part of efforts to drive antibiotic development to provide physicians with more tools, the company said.
Melinta is assessing the antibiotic in a clinical trial of patients with hospital-treated, community-acquired bacterial pneumonia and has planned studies on complicated urinary tract infections in the near future, ScinoPharm said.
A stronger New Taiwan dollar and shifts in the company’s product mix led to a drop in net income last quarter, ScinoPharm said.
Net income last quarter fell 51 percent quarter-on-quarter to NT$84 million (US$2.78 million), or earnings per share of NT$0.11, the company said.
Operating revenue and gross profit fell 7 percent and 31 percent quarterly to NT$853 million and NT$326 million respectively amid narrowing margins, it added.
Foreign exchange-related losses last quarter totaled NT$65 million, it said.
Apart from declining sales, the company also saw smaller sales contribution from higher-margin oncology products as its major international clients carry out consolidation plans.
Teva Pharmaceuticals Industries Ltd’s acquisition of Actavis Generics from Allergan Inc resulted in two clients cutting back contract manufacturing orders as they sort out overlapping product offerings, ScinoPharm said.
In addition, as more targeted cancer therapies emerge, consumption of drugs used in chemotherapy made by the company has declined, ScinoPharm said, adding that its drug manufacturing business is facing price competition from Indian companies.
Taiwan Transport and Storage Corp (TTS, 台灣通運倉儲) yesterday unveiled its first electric tractor unit — manufactured by Volvo Trucks — in a ceremony in Taipei, and said the unit would soon be used to transport cement produced by Taiwan Cement Corp (TCC, 台灣水泥). Both TTS and TCC belong to TCC International Holdings Ltd (台泥國際集團). With the electric tractor unit, the Taipei-based cement firm would become the first in Taiwan to use electric vehicles to transport construction materials. TTS chairman Koo Kung-yi (辜公怡), Volvo Trucks vice president of sales and marketing Johan Selven, TCC president Roman Cheng (程耀輝) and Taikoo Motors Group
Among the rows of vibrators, rubber torsos and leather harnesses at a Chinese sex toys exhibition in Shanghai this weekend, the beginnings of an artificial intelligence (AI)-driven shift in the industry quietly pulsed. China manufactures about 70 percent of the world’s sex toys, most of it the “hardware” on display at the fair — whether that be technicolor tentacled dildos or hyper-realistic personalized silicone dolls. Yet smart toys have been rising in popularity for some time. Many major European and US brands already offer tech-enhanced products that can enable long-distance love, monitor well-being and even bring people one step closer to
RECORD-BREAKING: TSMC’s net profit last quarter beat market expectations by expanding 8.9% and it was the best first-quarter profit in the chipmaker’s history Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), which counts Nvidia Corp as a key customer, yesterday said that artificial intelligence (AI) server chip revenue is set to more than double this year from last year amid rising demand. The chipmaker expects the growth momentum to continue in the next five years with an annual compound growth rate of 50 percent, TSMC chief executive officer C.C. Wei (魏哲家) told investors yesterday. By 2028, AI chips’ contribution to revenue would climb to about 20 percent from a percentage in the low teens, Wei said. “Almost all the AI innovators are working with TSMC to address the
Malaysia’s leader yesterday announced plans to build a massive semiconductor design park, aiming to boost the Southeast Asian nation’s role in the global chip industry. A prominent player in the semiconductor industry for decades, Malaysia accounts for an estimated 13 percent of global back-end manufacturing, according to German tech giant Bosch. Now it wants to go beyond production and emerge as a chip design powerhouse too, Malaysian Prime Minister Anwar Ibrahim said. “I am pleased to announce the largest IC (integrated circuit) Design Park in Southeast Asia, that will house world-class anchor tenants and collaborate with global companies such as Arm [Holdings PLC],”